These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8329703)

  • 1. Expression of platelet C1 inhibitor.
    Schmaier AH; Amenta S; Xiong T; Heda GD; Gewirtz AM
    Blood; 1993 Jul; 82(2):465-74. PubMed ID: 8329703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet C1- inhibitor. A secreted alpha-granule protein.
    Schmaier AH; Smith PM; Colman RW
    J Clin Invest; 1985 Jan; 75(1):242-50. PubMed ID: 3965505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1 inhibitor infusion modifies platelet activity in hereditary angioedema patients.
    Coppola L; Guastafierro S; Verrazzo G; Coppola A; De Lucia D; Tirelli A
    Arch Pathol Lab Med; 2002 Jul; 126(7):842-5. PubMed ID: 12088455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane expression of platelet calpain.
    Schmaier AH; Bradford HN; Lundberg D; Farber A; Colman RW
    Blood; 1990 Mar; 75(6):1273-81. PubMed ID: 2310827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and expression of C1 inhibitor by human umbilical vein endothelial cells.
    Schmaier AH; Murray SC; Heda GD; Farber A; Kuo A; McCrae K; Cines DB
    J Biol Chem; 1989 Oct; 264(30):18173-9. PubMed ID: 2478540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro interaction of C1-inhibitor with thrombin.
    Cugno M; Bos I; Lubbers Y; Hack CE; Agostoni A
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):253-60. PubMed ID: 11460008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients.
    Engel R; Rensink I; Roem D; Brouwer M; Kalei A; Perry D; Zeerleder S; Wouters D; Hamann D
    J Immunol Methods; 2015 Nov; 426():114-9. PubMed ID: 26318839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
    Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
    J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon gamma increases in vitro and in vivo expression of C1 inhibitor.
    Heda GD; Mardente S; Weiner L; Schmaier AH
    Blood; 1990 Jun; 75(12):2401-7. PubMed ID: 2112412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-molecular weight kininogen. A secreted platelet protein.
    Schmaier AH; Zuckerberg A; Silverman C; Kuchibhotla J; Tuszynski GP; Colman RW
    J Clin Invest; 1983 May; 71(5):1477-89. PubMed ID: 6406551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema--evidence of a functionally critical level of C1-inhibitor concentration.
    Späth PJ; Wüthrich B; Bütler R
    Complement; 1984; 1(3):147-59. PubMed ID: 6443347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune C1 inhibitor deficiency: report of eight patients.
    Cicardi M; Bisiani G; Cugno M; Späth P; Agostoni A
    Am J Med; 1993 Aug; 95(2):169-75. PubMed ID: 8356982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
    Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
    Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol.
    Pappalardo E; Zingale LC; Cicardi M
    Immunol Lett; 2003 May; 86(3):271-6. PubMed ID: 12706530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique talin antigenic determinant and anomalous megakaryocyte talin distribution associated with abnormal platelet formation in the Wistar Furth rat.
    Jackson CW; Hutson NK; Steward SA; Stenberg PE
    Blood; 1992 Apr; 79(7):1729-37. PubMed ID: 1373085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.
    Alsenz J; Lambris JD; Bork K; Loos M
    J Clin Invest; 1989 Jun; 83(6):1794-9. PubMed ID: 2723058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
    Kaplan AP; Gruber B; Harpel PC
    Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte C1-inhibitor synthesis in patients with C1-inhibitor deficiency.
    Lappin DF; McPhaden AR; Yap PL; Carter PE; Birnie GD; Fothergill JE; Whaley K
    Eur J Clin Invest; 1989 Feb; 19(1):45-52. PubMed ID: 2499461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1-inhibitor--biochemical properties and clinical applications.
    Al-Abdullah IH; Greally J
    Crit Rev Immunol; 1985; 5(4):317-30. PubMed ID: 3899511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.
    Landsem A; Nielsen EW; Fure H; Christiansen D; Ludviksen JK; Lambris JD; Østerud B; Mollnes TE; Brekke OL
    Clin Exp Immunol; 2013 Aug; 173(2):217-29. PubMed ID: 23607270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.